Glucose B. Braun

Glucose B. Braun is an intravenous solution for injection that contains glucose monohydrate as the active ingredient. It is supplied as a sterile liquid preparation without a specified strength label, intended for use in the European Union market. The product is classified as an excipient and is prescribed by healthcare professionals for various therapeutic purposes related to glucose provision and fluid management.

Glucose B. Braun is used in clinical settings to address several metabolic and fluid‑related needs.

- Treatment of hypoglycemia when rapid glucose replacement is required. - Fluid replacement and volume expansion in patients with dehydration or blood loss. - Component of parenteral nutrition regimens to supply carbohydrate calories. - Support of electrolyte balance during intravenous therapy. - Perioperative care to maintain blood glucose levels and intravascular volume. - Adjunct in managing hyperosmolar states under medical supervision.

Glucose B. Braun may be associated with a range of adverse reactions, most of which are related to its glucose content and intravenous administration.

Common: - Transient hyperglycemia or elevated blood glucose levels. - Local irritation or pain at the infusion site. - Phlebitis or inflammation of the vein. - Mild electrolyte disturbances, such as shifts in potassium or sodium. - Fluid overload manifested as peripheral edema. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia leading to diabetic ketoacidosis. - Anaphylactic or severe allergic reactions. - Significant volume overload causing pulmonary edema. - Metabolic acidosis in susceptible patients. - Severe electrolyte imbalance requiring urgent correction. - Hemolysis if incompatible solutions are co‑administered.

When prescribing or administering Glucose B. Braun, several safety considerations should be observed.

- Monitor blood glucose levels frequently, especially in diabetic patients. - Assess fluid status and avoid use in patients at risk of volume overload. - Check serum electrolytes before and during therapy to detect imbalances. - Use with caution in renal or hepatic impairment where glucose metabolism may be altered. - Pregnancy category is unknown; weigh potential benefits against risks in pregnant women. - Pediatric dosing requires individualized calculation based on weight and clinical condition. - Verify compatibility with other intravenous solutions to prevent precipitation or incompatibility reactions.

Glucose B. Braun can interact with other medications or solutions, influencing safety and efficacy.

Avoid: - Concurrent administration of high‑concentration dextrose solutions that may cause hyperosmolarity. - Insulin overdose without appropriate glucose supplementation. - Direct mixing with potassium chloride solutions, which may precipitate.

Use with caution: - Diuretics that may exacerbate electrolyte shifts. - Beta‑blockers, which can mask signs of hypoglycemia. - Corticosteroids, as they can increase blood glucose levels. - Other volume expanders, to prevent fluid overload. - Blood products, requiring careful monitoring of glucose and electrolyte balance.